Buy Crypto Markets Spot FuturesETH Earn Event Center Rewards Hub

Voyager Therapeutics, Inc. (VYGR)

NASDAQ

$3.20

$+0.01

(+0.31%)

Pre-Market

Voyager Therapeutics, Inc. (VYGR) Live Price Chart

Last updated: ⁦2026-09-14 09:13:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Voyager Therapeutics, Inc. (VYGR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.20, with a market capitalization of $196.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.94 to $5.55. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$196.56M
Open	$3.24
Day's High	$31.91
Day's Low	$2.46
Previous Close	$3.19
Volume	223.10K
Average Volume	583.89K
P/E Ratio	--
52-Week High	$5.55
52-Week Low	$2.94
Dividend Yield	--
Earnings Date	--

Voyager Therapeutics, Inc. (VYGR) Pre-Market Stock Price

Voyager Therapeutics, Inc. (VYGR) is trading at $3.31 in pre-market trading as of 2026-09-11 23:31:00, up 3.89% ($0.12) from the previous close of $3.19

Pre-market trading shows how investors are pricing VYGR before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Voyager Therapeutics, Inc. (VYGR) 7-Day Stock Price Change

Over the past seven days, Voyager Therapeutics, Inc. (VYGR) moved from $3.54 to $3.20, representing a decline of 9.75% ($0.35).

The stock traded between $3.13 and $3.59 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 437.36 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

VYGR 52-Week Price Position

Position in Range: 9.9%

52W Low$2.94

52W High$5.55

VYGR is currently trading at $3.20, placing it 9.9% of the way from its 52-week low of $2.94 to its 52-week high of $5.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Voyager Therapeutics, Inc. (VYGR)?

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Voyager Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	141
Exchange	NASDAQ
Company Website	https://www.voyagertherapeutics.com

How to Buy Voyager Therapeutics, Inc. (VYGR) Stock on MEXC

Eligible investors can buy real shares of Voyager Therapeutics, Inc. (VYGR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VYGR and Place Your Order

Open the RealStocks trading page and search for VYGR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Voyager Therapeutics, Inc. (VYGR) stock price today?

Voyager Therapeutics, Inc. (VYGR) is currently trading at $ 3.20, up 0.16% ($0.00) from the previous close of $ 3.19. Intraday prices update in real time during regular trading hours.

2.Is VYGR stock going up or down today?

As of 2026-09-11 23:31:00, VYGR is trading at $ 3.20, up 0.16% ($0.00) from its previous close of $ 3.19. The stock has traded between $ 2.46 and $ 31.91 during today’s regular session. Past price movements do not guarantee future results.

3.What is VYGR pre-market price?

As of 2026-09-11 23:31:00, VYGR is trading at $ 3.31 in pre-market trading, up 3.89% ($0.12) from the previous close of $ 3.19. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VYGR after-hours price?

As of 2026-09-11 23:31:00, VYGR is trading at $ 3.19 in after-hours trading, down 0.16% ($0.00) from the regular-session close of $ 3.19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VYGR stock trading now?

VYGR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VYGR sit relative to its 52-week high and low?

Over the past 52 weeks, VYGR has traded between a low of $ 2.94 and a high of $ 5.55. At $ 3.20, the stock is positioned 9.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Voyager Therapeutics, Inc. in?

Voyager Therapeutics, Inc. (VYGR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Voyager Therapeutics, Inc.'s market capitalization and where is it listed?

Voyager Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 196.56M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VYGR valued in terms of P/E ratio and EPS?

VYGR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.75. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Voyager Therapeutics, Inc. pay a dividend?

Voyager Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.